This transcript provides diagnostic strategies and pitfalls for differentiating Dermatofibrosarcoma Protuberans (DFSP) from other benign spindle cell lesions, such as neurofibroma and fibrous hamartoma. The speaker emphasizes that the classic feature of "fat trapping" is not specific to DFSP. To distinguish these entities, immunohistochemistry is crucial; while CD34 stains both DFSP and neurofibroma, the absence of S100 or Sox10 staining is a critical indicator for DFSP, as co-expression is "exquisitely rare." Furthermore, the speaker details the strategic use of Fluorescence In Situ Hybridization (FISH) for detecting the characteristic COL1A1-PDGFB translocation, particularly on small biopsies where immediate definitive diagnosis is necessary to determine if extensive surgery (for DFSP) or benign follow-up is appropriate.
0:06 Fat Trapping is Non-Specific: The feature of "fat trapping" (involving spindle cells infiltrating adipose tissue) is not unique to DFSP; it is also seen in diffuse neurofibroma and fibrous hamartoma.
0:35 IHC Differential Diagnosis: Both DFSP and most neurofibromas are CD34 positive. To distinguish them, add an S100 or Sox10 stain.
0:52 S100/Sox10 Rarity in DFSP: Positivity for S100 or Sox10 in true DFSP is "exquisitely rare," though the speaker notes one confirmed DFSP case that had patchy (5%) S100 expression in the fibrosarcomatous areas.
1:18 Molecular Confirmation: If uncertainty remains, use FISH testing to check for the COL1A1-PDGFB translocation. If negative, reflex testing for PDGFA/D fusions may be considered.
1:27 Strategic Use of FISH: The speaker primarily uses FISH when a biopsy shows a bland, CD34-positive spindle cell lesion, and they suspect the diagnosis is not DFSP.
1:36 Key Takeaway for Small Biopsies: Performing FISH immediately on a small biopsy is preferred to either misdiagnosing a benign lesion as DFSP (requiring big surgery) or delaying care by sending the patient back for a larger sample.